GRACE DILLARD: Open Payments
NPI 1013600915 · CARTHAGE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$792 in 54 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $36 · 2025 $792
Food & beverage: $792
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $240 |
| ABBVIE INC. | 24 | $229 |
| Corcept Therapeutics | 3 | $48 |
| Hologic Sales and Service, LLC | 2 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
| Novo Nordisk Inc | 2 | $42 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| Astellas Pharma US Inc | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
Products named: VRAYLAR, AIRSUPRA, BREZTRI, UBRELVY, Korlym, APTIMA, CAPLYTA, Auvelity.
Industry payments across TN — which companies pay providers there.
